GLP-1s are at the forefront of this change, and our work with Novo Nordisk serves as a blueprint for how pharma and digital health platforms can reimagine drug access models for the future, Iyer said
Maybe they view their investments and endorsements in entirely altruistic ways, but thats not how putting your face on a healthcare brands posters works
Recovery from workouts accelerates
Early research findings indicate that BPC-157 activates the FAKpaxillin pathway in cells, promoting cell migration and survival at injury sites
The early adopters, around 2024, were the people youd expect: bodybuilders and biohackers wiring crypto to Chinese sales reps on Telegram
6 With 11 brands already on the market and more than 40 more in the pipeline, 7 these medications will target the nearly 100 million Americans categorized as obese